Tarsus Pharmaceuticals to present 11 abstracts at American Academy of Optometry annual meeting

By Public Technologies
  • Tarsus Pharmaceuticals to present 11 scientific abstracts at the American Academy of Optometry 2026 Annual Meeting, Sept. 30-Oct. 3, 2026.
  • Sessions scheduled in Anaheim, California, including poster presentations on Oct. 1, 2026, 4:30-6:30 p.m. PDT.
  • One paper presentation set for Oct. 2, 2026, 4:00-4:15 p.m. PDT.
  • Program highlights real-world outcomes with XDEMVY (lotilaner ophthalmic solution) 0.25%, Demodex blepharitis, ocular rosacea.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tarsus Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609290830PRIMZONEFULLFEED9835468) on September 29, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.
The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.
To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.